Clinical and genetic features of patients with sporadic amyotrophic lateral sclerosis in south-west China

Amyotrophic Lateral Sclerosis

Volumn 10, Issue 5-6, 2009, Pages 350-354

  Fang, Deng Fu ^a   Zhang, Shu Shan ^a   Guo, Xiao Yan ^a   Zeng, Yan ^a   Yang, Yuan ^a   Zhou, Dong ^a   Shang, Hui Fang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CHINA; CLINICAL FEATURE; DISEASE DURATION; FASCICULATION; FEMALE; FLF10986 GENE; FOLLOW UP; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; THERAPY DELAY;

ADULT; AGE OF ONSET; AGED; AMYOTROPHIC LATERAL SCLEROSIS; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 70450202250     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482960802668646     Document Type: Article

References (29)

1. Rowland LP, Shnei Der NA. Amyotrophic lateral Sclerosis. New England Journal of Medicine. 2001;344:1688-700.
2. Pasinelli P, Brown R. Molecular biology of amyotrophic lateral sclerosis: Insights from genetics. Nature Review Neuroscience. 2006;7:710-23.
3. Simpson CL, Al-Chalabi A. Amyotrophic lateral sclerosis as a complex genetic disease. Biochimica et Biophysica Acta. 2006;1762:973-85.
4. Rosen DR, Siddique T, Patterson D, et al. Mutations in the Cu/Zn superoxi De dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59-62.
5. Corrado L, D'Alfonso S, Bergamaschi L, Testa L, Leone M, Nasuelli N, et al. SOD1 gene mutations in Italian patients with Sporadic Amyotrophic Lateral Sclerosis (ALS). Neuromuscul Disord 2006;16:800-804.
6. Jones CT, Swingler RJ, Simpson SA, Brock DJ. Superoxi De dismutase mutations in an unselected cohort of Scottish amyotrophic lateral sclerosis patients. J Med Genet 1995; 32:290-292.
7. Schymick JC, Scholz SW, Fung HC, Britton A, Arepalli S, Gibbs JR. Genome-wi De genotyping in amyotrophic lateral sclerosis and neurologically normal controls: First stage analysis and public release of data. Lancet Neurology 2007;6:322-328.
8. Cronin S, Berger S, Ding J, Schymick JC, Washecka N, Hernan Dez DG, et al. A genome-wi De association study of sporadic ALS in a homogenous Irish population. Human Molecular Genetics 2008;17:768-774.
9. Dunckley T, Huentelman MJ, Craig DW, et al. Wholegenome analysis of sporadic amyotrophic lateral sclerosis. The New England Journal of Medicine. 2007;357:775-88.
10. Brooks BR. El Escorial World Fe Deration of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Fe Deration of Neurology Research Group on Neuromuscular Diseases and the El Escorial 'Clinical limits of amyotrophic lateral sclerosis' workshop contributors. Journal of the Neurological Sciences. 1994;124:96-107.
11. Group ACTS Phase I-II. The amyotrophic lateral sclerosis functional rating scale: Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Archives of Neurology. 1996;53:141-7.
12. Yao XL, Zhang C, Sheng WL, Liang YX. Amyotrophic lateral sclerosis diagnosis and analysis of causes (with 238 cases of reported cases). Chinese Journal of Nervous and Mental Diseases. 2001;27:218-20.
13. Duan F, Pu CP, Lang SY,WuW P. Clinical study of 105 cases of amyotrophic lateral sclerosis. Aca Demic Journal of Pla Postgraduate Medical School. 2002;23:11-3.
14. Nalini A, Thennarasu K, Gourie-Devi M, Shenoy S, Kulshreshtha D. Clinical characteristics and survival pattern of 1,153 patients with amyotrophic lateral sclerosis: Experience over 30 years from India. J Neurol Sci 2008;272:60-70.
15. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a mo Del for survival prediction. Brain 1995;118 (Pt 3):707-719.
16. Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G. Inci Dence of ALS in Lombardy, Italy. Neurology. 2007;68:141-5.
17. O'Toole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B, et al. Epi Demiology and clinical features of amyotrophic lateral sclerosis in Ireland between and 2004. J Neurol Neurosurg Psychiatry. 1995;2007:18.
18. Mandrioli J, Faglioni P, Merelli E, Sola P. The epi Demiology of ALS in Mo Dena, Italy. Neurology. 2003;60:683-9.
19. Sorenson EJ, Stalker AP, Kurland LT, Win Debank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925-1998. Neurology. 2002;59:280-2.
20. Millul A, Beghi E, Logroscino G, Micheli A, Vitelli E, Zardi A. Survival of patients with amyotrophic lateral sclerosis in a population-based registry. Neuroepi Demiology. 2005;25: 114-9.
21. Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, et al. ALS prognosis is heterogeneous across different phenotypes: A population-based study. J Neurol Neurosurg Psychiatry. 2007;5.
22. Chen D, Shen L, Wang L, Lu A, Zhang H, Zhang X, et al. Association of polymorphisms in vascular endothelial growth factor gene with the age of onset of amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2007;8:144-149.
23. Werneck LC, Bezerra R, Silveira, Neto O, Scola RH. A clinical epi Demiological study of 251 cases of amyotrophic lateral sclerosis in the south of Brazil. Arq Neuropsiquiatr. 2007;65:189-95.
24. Forbes RB, Colville S, Swingler RJ. The epi Demiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 years or above. Age and Ageing. 2004;33:131-4.
25. Del Aguila MA, Longstreth WT, McGuire V, Koepsell TD, Van Belle G. Prognosis in amyotrophic lateral sclerosis: A population-based study. Neurology. 2003;11:813-9.
26. Czaplinski A, Yen AA, Appel SH. Amyotrophic lateral sclerosis: Early predictors of prolonged survival. J Neurol. 2006;253:1428-36.
27. Preux PM, Couratier P, Boutros-Toni F, Salle JY, Tabaraud F, Bernet-Bernady P, et al. Survival prediction in sporadic amyotrophic lateral sclerosis. Age and clinical form at onset are in Depen Dent risk factors. Neuroepi Demiology. 1996; 15:153-60.
28. Mandrioli J, Faglioni P, Nichelli P, Sola P. Amyotrophic lateral sclerosis: Prognostic indicators of survival. Amyotrophic Lateral Sclerosis. 2006;7:211-20.
29. Mannino M, Cellura E, Grimaldi G, Volanti P, Piccoli F, La Bella V. Telephone follow-up for patients with amyotrophic lateral sclerosis. European Journal of Neurology. 2007;14: 79-84.